Long term efficacy and toxicity after stereotactic ablative reirradiation in locally relapsed stage III non-small cell lung cancer

BACKGROUND: In stage III non-small cell lung cancer (NSCLC) treated with concomitant chemoradiotherapy, there is a high rate of relapse. Some of these relapses are only local and can be treated by stereotactic ablative radiation therapy (SABR). Previous studies reporting outcome after SABR reirradia...

Descripción completa

Detalles Bibliográficos
Autores principales: Sumodhee, Shakeel, Bondiau, Pierre-Yves, Poudenx, Michel, Cohen, Charlotte, Naghavi, Arash O., Padovani, Bernard, Maneval, Daniel, Gal, Jocelyn, Leysalle, Axel, Ghalloussi, Hannah, Otto, Josiane, Doyen, Jérôme
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6448259/
https://www.ncbi.nlm.nih.gov/pubmed/30943943
http://dx.doi.org/10.1186/s12885-019-5542-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6448259/
https://www.ncbi.nlm.nih.gov/pubmed/30943943
http://dx.doi.org/10.1186/s12885-019-5542-3

Ejemplares similares